Clinical Transplantation

Papers
(The median citation count of Clinical Transplantation is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Incidence, risk factors, treatment, and consequences of antibody‐mediated kidney transplant rejection: A systematic review48
Outcomes of COVID‐19 in hospitalized solid organ transplant recipients compared to a matched cohort of non‐transplant patients at a national healthcare system in the United States44
SARS‐COV‐2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications43
Pig kidney xenotransplantation: Progress toward clinical trials38
Early United States experience with liver donation after circulatory determination of death using thoraco‐abdominal normothermic regional perfusion: A multi‐institutional observational study37
Excess mortality in solid organ transplant recipients hospitalized with COVID‐19: A large‐scale comparison of SOT recipients hospitalized with or without COVID‐1936
Intraoperative transfusion management, antifibrinolytic therapy, coagulation monitoring and the impact on short‐term outcomes after liver transplantation—A systematic review of the literature and expe36
Bamlanivimab for treatment of COVID‐19 in solid organ transplant recipients: Early single‐center experience33
Does liver biopsy accurately measure fibrosis in Fontan‐associated liver disease? A comparison of liver biopsy pre–combined heart and liver transplant and liver explant post‐transplant32
State‐of‐the‐art machine learning algorithms for the prediction of outcomes after contemporary heart transplantation: Results from the UNOS database30
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS‐CoV‐2 vaccine27
Evolving utilization of donation after circulatory death livers in liver transplantation: The day of DCD has come27
Does machine perfusion improve immediate and short‐term outcomes by enhancing graft function and recipient recovery after liver transplantation? A systematic review of the literature, meta‐analysis an27
Enhanced recovery after surgery programs improve short‐term outcomes after liver transplantation–A systematic review and meta‐analysis27
Transplant outcomes using kidneys from high KDPI acute kidney injury donors24
Impact of heart transplant allocation change on competing waitlist outcomes among listing strategies23
The changing landscape of pediatric lung transplantation21
Donor‐derived cell‐free DNA is associated with cardiac allograft vasculopathy21
Perioperative fluid management and outcomes in adult deceased donor liver transplantation – A systematic review of the literature and expert panel recommendations21
Removal of the Black race coefficient from the estimated glomerular filtration equation improves transplant eligibility for Black patients at a single center20
Impact of pre‐transplant carbapenem‐resistant Enterobacterales colonization and/or infection on solid organ transplant outcomes20
Using race to estimate glomerular filtration and its impact in kidney transplantation20
Gut microbiota profiles and fecal beta‐glucuronidase activity in kidney transplant recipients with and without post‐transplant diarrhea20
COVID‐19 in hospitalized liver transplant recipients: An early systematic review and meta‐analysis20
What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? A systematic review of the literature and expert panel recommendations19
Extracorporeal photopheresis and its role in heart transplant rejection: prophylaxis and treatment18
Abdominal wall complications after kidney transplantation: A clinical review17
Does modification of portal pressure and flow enhance recovery of the recipient after living donor liver transplantation? A systematic review of literature and expert panel recommendations17
Lung transplantation for the treatment of irreversible acute respiratory distress syndrome17
Pediatric lung transplantation as standard of care17
Prevalence and characterization of frailty, depression, and cognitive impairment in patients listed for heart transplantation: Results of the FELICITAR prospective registry16
Influence of patient characteristics and immunosuppressant management on mortality in kidney transplant recipients hospitalized with coronavirus disease 2019 (COVID‐19)16
eHealth literacy and web‐based patient portal usage among kidney and liver transplant recipients16
Hyperammonemia syndrome associated with Ureaplasma spp. Infections in immunocompromised patients and transplant recipients: A systematic review and meta‐analysis15
Sodium‐glucose cotransporter 2 inhibitors for treatment of diabetes mellitus after kidney transplantation15
Nitazoxanide treatment for norovirus infection in solid organ transplant recipients15
Normothermic with or without hypothermic oxygenated perfusion for DCD before liver transplantation: European multicentric experience15
Operational challenges in the COVID‐19 era: Asymptomatic infections and vaccination timing15
Magnetic resonance imaging‐derived proton density fat fraction (MRI‐PDFF) is a viable alternative to liver biopsy for steatosis quantification in living liver donor transplantation15
The type of SARS‐CoV‐2 vaccine influences serological response in kidney transplant recipients15
Transplantation of kidneys after normothermic perfusion: A single center experience15
Wait expectations: The impact of delisting as an outcome from the kidney transplant waitlist15
Acute kidney injury post‐heart transplant: An analysis of peri‐operative risk factors15
Sex and gender disparity in kidney transplantation: Historical and future perspectives14
Association of race and gender with primary caregiver relationships and eligibility for advanced heart failure therapies14
Impact of the United Network for organ sharing 2018 donor heart allocation system on transplant morbidity and mortality14
Impact of the duration of normothermic regional perfusion on the results of liver transplant from controlled circulatory death donors: A retrospective, multicentric study14
Left‐digit bias and deceased donor kidney utilization14
Kidney allograft rejection: Diagnosis and treatment practices in USA‐ A UNOS survey14
The impact of the SARS‐CoV‐2 pandemic and COVID‐19 on lung transplantation in the UK: Lessons learned from the first wave14
Renal transplantation during the SARS‐CoV‐2 pandemic in the UK: Experience from a large‐volume center13
Impact of UNOS allocation policy changes on utilization and outcomes of patients bridged to heart transplant with intra‐aortic balloon pump13
SARS‐CoV‐2 infection increases tacrolimus concentrations in solid‐organ transplant recipients13
Adult liver transplant anesthesiology practice patterns and resource utilization in the United States: Survey results from the society for the advancement of transplant anesthesia13
Infectious complications in allogeneic hematopoietic cell transplant recipients: Review of transplant‐related risk factors and current state of prophylaxis13
Immune response to third SARS‐CoV‐2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction13
What is the optimal anesthetic monitoring regarding immediate and short‐term outcomes after liver transplantation?—A systematic review of the literature and expert panel recommendations13
Mobile health technology to improve emergent frailty after lung transplantation13
Letermovir treatment for CMV infection in kidney and pancreas transplantation: A valuable option for complicated cases13
The role of prehabilitation on short‐term outcomes after liver transplantation: A review of the literature and expert panel recommendations13
Meta‐analysis and systematic review: Prevalence, graft failure, mortality, and post‐operative thrombosis in liver transplant recipients with pre‐operative portal vein thrombosis13
Decreased frequency of transplantation and lower post‐transplant survival free of re‐transplantation in LVAD patients with the new heart transplant allocation system13
Levels of donor‐derived cell‐free DNA and chemokines in BK polyomavirus‐associated nephropathy12
Immunosuppression practices during the COVID‐19 pandemic: A multinational survey study of transplant programs12
Which cava anastomotic techniques are optimal regarding immediate and short‐term outcomes after liver transplantation: A systematic review of the literature and expert panel recommendations12
The role of preoperative optimization of the nutritional status on the improvement of short‐term outcomes after liver transplantation? A review of the literature and expert panel recommendations12
Incidence and risk factors of primary non‐function after liver transplantation using grafts from uncontrolled donors after circulatory death12
Which preoperative assessment modalities best identify patients who are suitable for enhanced recovery after liver transplantation? A systematic review of the literature and expert panel recommendatio12
Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients12
User‐centered design features for digital health applications to support physical activity behaviors in solid organ transplant recipients: A qualitative study12
A retrospective multi‐center experience of renal transplants from India during COVID‐19 pandemic12
The incidence, clinical outcome, and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemia12
ProtekDuo as a bridge to lung transplant and heart‐lung transplant12
Variations in deceased donor kidney procurement biopsy practice patterns: A survey of U.S. organ procurement organizations12
Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization12
Histopathologic findings on indication renal allograft biopsies after recovery from acute COVID‐1911
Adoption of a novel smart mobile‐health application technology to track chronic immunosuppression adherence in solid organ transplantation: Results of a prospective, observational, multicentre, pilot 11
Cognitive impairment burden in older and younger adults across the kidney transplant care continuum11
The impact of depression on heart transplant outcomes: A retrospective single‐center cohort study11
COVID‐19 in heart transplant recipients during February–August 2020: A systematic review11
Impella 5.5 as a bridge to heart transplantation: Waitlist outcomes in the United States11
Blood product transfusion and lung transplant outcomes: A systematic review11
Current status and further potential of lung donation after circulatory death11
The role of early extubation on short‐term outcomes after liver transplantation – A systematic review, meta‐analysis and expert recommendations11
The impact of marijuana use on liver transplant recipients: A 900 patient single center experience11
Longitudinal variance of Donor‐Derived Cell‐Free DNA (dd‐cfDNA) in Stable Kidney Transplant (KTx) patients are influenced by donor/recipient variables11
Quick preparation of ABO‐incompatible living donor liver transplantation for acute liver failure11
Takotsubo syndrome after liver transplantation: An association with intraoperatively administered epinephrine and fentanyl11
Availability of PEth testing is associated with reduced eligibility for liver transplant among patients with alcohol‐related liver disease11
Hemophagocytic lymphohistiocytosis occurring after liver transplantation: A case series and review of the literature11
Textbook surgical outcome in lung transplantation: Analysis of a US national registry11
Blood transfusion of the donor is associated with stage 3 primary graft dysfunction after lung transplantation11
Optimal anesthetic conduct regarding immediate and short‐term outcomes after liver transplantation – Systematic review of the literature and expert panel recommendations11
Telemedicine based remote monitoring after liver transplantation: Feasible in a select group and a more stringent control of immunosuppression11
Perioperative management of living donor liver transplantation: Part 2 – Donors10
Clinical outcome of kidney transplantation after bariatric surgery: A single‐center, retrospective cohort study10
Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low‐dose corticosteroids in primary kidney transplantation: 18‐year results10
A comprehensive review of Strongyloides stercoralis infection after solid organ and hematopoietic stem cell transplantation10
Long‐term outcomes of Roux‐en‐Y gastric bypass or sleeve gastrectomy in patients with cirrhosis; before, during or after liver transplantation: A single center's experience10
Podocyte density is reduced in kidney allografts with high‐risk APOL1 genotypes at transplantation10
Outcomes of hepatitis C virus nucleic acid testing positive donors in aviremic recipients with delayed direct‐acting antiviral initiation10
Impact of induction therapy on outcomes after heart transplantation10
Increased frequency of heart transplantation, shortened waitlist time and preserved post‐transplant survival in adults with congenital heart disease, on the new heart transplant allocation system10
Geographic disparities in heart transplantation persist under the new allocation policy10
Surgical complications after living and deceased donor liver transplant: The NSQIP transplant experience10
The role of acute in‐patient rehabilitation on short‐term outcomes after liver transplantation: A systematic review of the literature and expert panel recommendations10
Packing the donor heart: Is SherpaPak cold preservation technique safer compared to ice cold storage10
Lung transplantation from donation after circulatory death, evolution, and current status in the United States10
Impact of donor smoking history on post heart transplant outcomes: A propensity‐matched analysis of ISHLT registry10
Induction immunosuppression and the risk of incident malignancies among older and younger kidney transplant recipients: A prospective cohort study10
Optimal management of perioperative analgesia regarding immediate and short‐term outcomes after liver transplantation – A systematic review, meta‐analysis and expert panel recommendations10
Combining donor derived cell free DNA and gene expression profiling for non‐invasive surveillance after heart transplantation9
Observed elevated donor‐derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection9
Avoiding surveillance biopsy: Use of a noninvasive biomarker assay in a real‐life scenario9
Sweet and simple as syrup: A review and guidance for use of novel antihyperglycemic agents for post‐transplant diabetes mellitus and type 2 diabetes mellitus after kidney transplantation9
Predictive score for immediate extubation after liver transplantation9
Optimal surgical workup to ensure safe recovery of the donor after living liver donation – A systematic review of the literature and expert panel recommendations9
Long‐term outcomes in kidney transplant recipients with end‐stage kidney disease due to anti‐glomerular basement membrane disease9
Managing the significant drug‐drug interaction between tacrolimus and letermovir in solid organ transplant recipients9
Impact of COVID‐19 pandemic on the size of US transplant waiting lists9
Transplantation of liver from hepatitis C–infected donors to hepatitis C RNA–negative recipients: Histological and virologic outcome9
Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States9
Impact of the heart transplant allocation policy change on inpatient cost of index hospitalization9
Exercise‐based rehabilitation strategies in heart transplant recipients: Focus on high‐intensity interval training9
Size matching in heart transplantation: Is predicted heart mass the optimal method in a United Kingdom cohort?9
Living donor liver transplant candidate and donor selection and engagement: Meeting report from the living donor liver transplant consensus conference9
What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and 9
Primary biliary cholangitis has the highest waitlist mortality in patients with cirrhosis and acute on chronic liver failure awaiting liver transplant9
Tocilizumab for treatment of chronic active antibody‐mediated rejection in kidney transplant recipients9
Karnofsky performance status predicts outcomes in candidates for simultaneous liver‐kidney transplant9
Single‐center experience with nirmatrelvir/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression9
Post‐transplant inotrope score is associated with clinical outcomes after adult heart transplantation9
Racial disparities in living donor kidney transplantation in the United States9
Impact of diabetes mellitus on clinical outcomes after heart transplantation9
Transplant kidney biopsy for proteinuria with stable creatinine: Findings and outcomes8
Better outcome of COVID‐19 positive kidney transplant recipients during the unremitting stage with optimized anticoagulation and immunosuppression8
In kidney recipients from the same deceased donor, discordance in delayed graft function is associated with the worst outcomes8
First‐day plasma amylase detects patients at risk of complications after simultaneous pancreas‐kidney transplantation8
Effectiveness and safety of glucagon‐like peptide‐1 receptor agonist in a cohort of kidney transplant recipients8
“The use of bilateral continuous erector spinae plane blocks for postoperative analgesia after right‐sided living donor hepatectomy: A feasibility study”8
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation8
Cardiac transplantation in adult congenital heart disease with prior sternotomy8
Multimodal opioid‐sparing pain management after lung transplantation and the impact of liposomal bupivacaine intercostal nerve block8
Comparison of two donor‐derived cell‐free DNA tests and a blood gene‐expression profile test in heart transplantation8
Liver transplantation for combined hepatocellular‐cholangiocarcinoma: Outcomes and prognostic factors for mortality. A multicenter analysis8
Outcomes of living‐donor liver transplantation for acute‐on‐chronic liver failure based on newly proposed criteria in Japan8
The role of graft to recipient weight ratio on enhanced recovery of the recipient after living donor liver transplantation – A systematic review of the literature and expert panel recommendations8
Lung transplantation outcomes after crossing low‐level donor specific antibodies without planned augmented immunosuppression8
Changes in waitlist and posttransplant outcomes in patients with adult congenital heart disease after the new heart transplant allocation system8
Does prolonged cold ischemia affect outcomes in donation after cardiac death donor kidney transplants?8
Outcomes of kidney donors with pre‐ and post‐donation kidney stones8
Machine learning‐based prediction of mortality after heart transplantation in adults with congenital heart disease: A UNOS database analysis8
Acute kidney injury during pregnancy in kidney transplant recipients8
Incidence, risk factors, and long‐term outcomes associated with antibody‐mediated rejection — The long‐term Deterioration of Kidney Allograft Function (DeKAF) prospective cohort study8
An evaluation of the safety and preliminary efficacy of peri‐ and post‐operative treprostinil in preventing ischemia and reperfusion injury in adult orthotopic liver transplant recipients8
Successful outcomes with transplanting kidneys from deceased donors with acute kidney injuryon temporary renal replacement therapy8
Single‐center utilization of donor‐derived cell‐free DNA testing in the management of heart transplant patients8
A comparison of cardiopulmonary bypass versus extracorporeal membrane oxygenation: Does intraoperative circulatory support strategy affect outcomes in pediatric lung transplantation?8
Airway complications in lung transplant recipients with telomere‐related interstitial lung disease8
Analysis of individual components of frailty: Pre‐transplant grip strength is the strongest predictor of post kidney transplant outcomes8
One‐year immunologic outcomes of lung transplantation utilizing hepatitis C‐viremic donors8
Ethical considerations regarding COVID‐19 vaccination for transplant candidates and recipients8
When is it safe to perform abdominal transplantation in patients with prior SARS‐CoV‐2 infection: A case series8
Can direct oral anticoagulants be used in kidney transplant recipients?8
Biomarkers and predictive models of early allograft dysfunction in liver transplantation – A systematic review of the literature, meta‐analysis, and expert panel recommendations8
The MMDx®diagnostic system: A critical re‐appraisal of its knowledge gaps and a call for rigorous validation studies8
Video education to facilitate patient outreach about living kidney donation: A proof of concept8
Recipient age and outcomes following simultaneous pancreas‐kidney transplantation in the new millennium: Single‐center experience and review of the literature8
Pancreas transplantation would be easy if the recipients were not diabetic: A practical guide to post‐operative management of diabetic complications in pancreas transplant recipients8
Kidney utilization and outcomes of liver transplant recipients who were listed for kidney after liver transplant after the implementation of safety net policy8
Transcriptional analysis identifies potential novel biomarkers associated with successful ex‐vivo perfusion of human donor lungs8
Donor supply for partial heart transplantation in the United States8
Treatment of steroid‐refractory chronic graft‐versus‐host disease with imatinib: Real‐life experience of the Spanish group of hematopoietic transplantation (GETH)7
Race does not predict pancreas graft failure after pancreas transplantation in the modern era7
Trends in organ donation and transplantation over the past eighteen years in Iran7
Identification of cell‐free DNA methylation patterns unique to the human left ventricle as a potential indicator of acute cellular rejection7
Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis influence suitability for and outcome after living donor liver transplantation? A systematic review o7
Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference7
Gastric peroral endoscopic myotomy (GPOEM) for severe gastroparesis after lung transplantation: A promising minimally invasive option7
De novo tacrolimus extended‐release tablets (LCPT) versus twice‐daily tacrolimus in adult heart transplantation: Results of a single‐center non‐inferiority matched control trial7
Decreased Nutritional Risk Index is associated with mortality after heart transplantation7
Utilizing multimodal analgesia to evaluate postoperative analgesic requirements in kidney transplant recipients7
The Molecular Microscope (MMDXR) interpretation of thoracic and abdominal allograft biopsies: Putting things in perspective for the clinician7
Marijuana use among adult liver transplant candidates and recipients7
Intermediate‐term outcomes of heart transplantation for cardiac amyloidosis in the current era7
Center variations in patient selection for simultaneous heart‐kidney transplantation7
Bioavailability of once‐daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study7
Post‐transplant lymphoproliferative disorder with cutaneous involvement: A series of four cases7
Long‐term outcomes of kidney transplantation from deceased donors with terminal acute kidney injury: Single center experience and literature review7
Financial, policy, and ethical barriers to the expansion of living donor liver transplant: Meeting report from a living donor liver transplant consensus conference7
Hydroxychloroquine and maintenance immunosuppression use in kidney transplant recipients: Analysis of linked US registry and claims data7
Early onset of azithromycin to prevent CLAD in lung transplantation: Promising results of a retrospective single centre experience7
Designing a patient‐specific search of transplant program performance and outcomes: Feedback from heart transplant candidates and recipients7
Organ transplant and Covid‐19 vaccination: Considering the ethics of denying transplant to unvaccinated patients7
Pre‐transplant cognitive screening is a poor predictor of post‐transplant cognitive status7
Sex mismatch following heart transplantation in the United States: Characteristics and impact on outcomes7
Kidney utility and futility7
Pancreas transplantation perceptions and practice: Results from a national US survey7
Critical interactions between race and the highly granular area deprivation index in liver transplant evaluation7
Predictive value of chart‐based frailty evaluation for lung transplant candidates7
A systematic review of living kidney donor enhanced recovery after surgery7
Intravascular ultrasound–guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients7
Outcomes of living liver donor candidate evaluations in the Living Donor Collective pilot registry7
Donor management using a specialized donor care facility is associated with higher organ utilization from drug overdose donors7
Torquetenovirus viral load is associated with anti‐spike antibody response in SARS‐CoV‐2 mRNA BNT162b2 vaccinated kidney transplant patients7
The effects of donor‐specific antibody characteristics on cardiac allograft vasculopathy7
Six‐month risk of Pneumocystis pneumonia following acute cellular rejection: A case‐control study in solid organ transplant recipients7
NSAID prescriptions in kidney transplant recipients7
Impact of donation after circulatory death heart transplantation on waitlist outcomes and transplantation activity7
The efficacy of interleukin‐1 antagonist
drugs in combination with colchicine in patients with FMF‐AA with colchicine resistance after kidney transplantation: A study with histopathologic evidence7
BK virus nephropathy in non‐renal solid organ transplant recipients: Are we looking hard enough?7
Improved surgical outcomes following simultaneous pancreas‐kidney transplantation in the contemporary era7
Use of letermovir‐valganciclovir combination as a step‐down treatment after foscarnet for ganciclovir‐resistant CMV infection in kidney transplant recipients7
Outcomes among CMV‐mismatched and highly sensitized kidney transplants recipients who develop neutropenia7
Incidence, mortality, and risk factors associated with carbapenem‐resistant Acinetobacter baumannii bacteremia within 30 days after liver transplantation7
Implementation of patient‐reported outcome measures in a heart transplant recipient registry: First step toward a patient‐centered approach7
Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients7
Liver transplant after donation from controlled circulatory death versus brain death: A UNOS database analysis and publication bias adjusted meta‐analysis7
Benefits of both physical assessment and electronic health record review to assess frailty prior to heart transplant7
Less bleeding associated with apixaban versus other direct acting oral anticoagulation in solid organ transplant recipients6
Use of Continuous Glucose Monitoring for evaluation of hypoglycemia pre‐ and post‐operatively for patients undergoing Total Pancreatectomy with Autologous Islet Cell Transplant6
Eliminating racial disparities in kidney transplantation6
Does multimodal perioperative pain management enhance immediate and short‐term outcomes after living donor partial hepatectomy? A systematic review of the literature and expert panel recommendations6
Association of CMV‐specific T‐cell immunity and risk of CMV infection in lung transplant recipients6
Association between dd‐cfDNA levels, de novo donor specific antibodies, and eGFR decline: An analysis of the DART cohort6
Prognostic value of cardiopulmonary exercise test after heart transplantation6
Current opinions on DGF management practices: A survey of the United States and Canada6
Does pediatric heart transplant survival differ with various cardiac preservation solutions?6
Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular function in patients with orthotopic heart transplantation6
The effect of antiplatelet therapy on survival and cardiac allograft vasculopathy following heart transplantation: A systematic review and meta‐analysis6
Outcome of liver transplantation and prevalence of liver fibrosis in Crigler‐Najjar syndrome6
Serum Mac‐2 binding protein glycosylation isomer as a biomarker of fibrosis in living donor liver transplant graft6
COVID‐19 test result reporting for deceased donors: Emergent policies, logistical challenges, and future directions6
Autoantibodies to LG3 are associated with poor long‐term survival after liver retransplantation6
The optimal immunosuppression management to prevent early rejection after liver transplantation: A systematic review of the literature and expert panel recommendations6
Toward telemedicine‐compatible physical functioning assessments in kidney transplant candidates6
Patient‐reported outcomes after Tixagevimab and Cilgavimab pre‐exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of risk6
Rabbit anti‐thymocyte globulin administration to treat rejection in simultaneous pancreas and kidney transplant recipients with recent COVID‐19 infection6
EXPloring attitudes and factors influencing reproductive Choices in kidney Transplant patients (The EXPECT‐study)6
Tacrolimus time‐in‐therapeutic range is associated with freedom from acute rejection and graft failure following intestinal transplantation6
Outcome of kidney transplantations from ≥65‐year‐old deceased donors with acute kidney injury6
Cannulation‐related adverse events of peripheral veno‐arterial extracorporeal membrane oxygenation support in heart transplantation: Axillary versus femoral artery cannulation6
The volume‐outcomes relationship in donation after circulatory death liver transplantation6
Impact of SIRPα polymorphism on transplant outcomes in HLA‐identical living donor kidney transplantation6
Formation of donor‐specific antibodies depends on the epitope load of mismatched HLAs in lung transplant recipients: A retrospective single‐center study6
Comparing outcomes in right versus left kidney transplantation: A systematic review and meta‐analysis6
COVID‐19 in heart transplant recipients—A seroprevalence survey6
Evolving challenges with long‐term care of liver transplant recipients6
Letermovir for cytomegalovirus prophylaxis in high‐risk heart transplant recipients6
Impact of the donor hepatectomy time on short‐term outcomes in liver transplantation using donation after circulatory death: A review of the US national registry6
0.057886123657227